Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization. Shanmugalingam A, Hitos K, Pathmanathan N, Edirimmane S, et al. Breast Cancer Res Treat 2023 Jan 5. doi: 10.1007/s10549-023-06860.

Read + Share

Amedeo Smart

Independent Medical Education

Shanmugalingam A, Hitos K, Pathmanathan N, Edirimmane S, et al. Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization. Breast Cancer Res Treat 2023 Jan 5. doi: 10.1007/s10549-023-06860.
PMID: 36604351